Posted in | News | Mining Business

Mining Industry Concerned With Growing Use of Synthetic Drug

Australian miners seem to be working ‘high’ on a drug similar to cannabis. The substance called Kronic is marketed as, “the closest thing to legal weed on the market”. Made in New Zealand, Kronic can be bought legally and is undetectable via on site drug tests.

It is dangerous as health officials from the West Australian Drug and Alcohol Authority have confirmed that it imitates the effect of cannabis such as producing a high, causing fatigue, headaches, disorientation, and hallucinations in users. These can be potentially problematic at work.

Mining giants BHP Billiton and Rio Tinto have expressed concern about the usage of the drug as it would potentially affect workplace safety in the industry. The West Australian Chamber of Minerals and Energy called for an investigation into the drug usage.

The Western Australia Premier Colin Barnett said that if it is harmful and has the same harmful effects as cannabis, which includes all sorts of physical and mental effects, then we would look at whether it should be available for sale here.

The Drug and Alcohol Office's Gary Kirby said users of the drug suffered short-term fatigue, dehydration, nausea and headaches. Mr Kirbysaid other countries reported that it caused agitation, anxiety, nausea, vomiting and disorientation. He added that it was banned in some countries. It alters mood and perception and should be avoided.

The manufacturer does warn not to attempt to drive or operate heavy machinery while under the influence of Kronic.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, March 19). Mining Industry Concerned With Growing Use of Synthetic Drug. AZoMining. Retrieved on November 22, 2024 from https://www.azomining.com/News.aspx?newsID=3911.

  • MLA

    Scanlon, Joel. "Mining Industry Concerned With Growing Use of Synthetic Drug". AZoMining. 22 November 2024. <https://www.azomining.com/News.aspx?newsID=3911>.

  • Chicago

    Scanlon, Joel. "Mining Industry Concerned With Growing Use of Synthetic Drug". AZoMining. https://www.azomining.com/News.aspx?newsID=3911. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. Mining Industry Concerned With Growing Use of Synthetic Drug. AZoMining, viewed 22 November 2024, https://www.azomining.com/News.aspx?newsID=3911.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.